Physician

Zackary Bryce Whitney, DO

According to 2025 Medicare claims, Zackary Whitney, DO (NPI: 1942763941) practices dermatology in the Wildwood-The Villages, FL market, with the plurality of this provider's patient population coming from Sumter, FL. This provider's primary affiliated billing organization is LEAVITT MEDICAL ASSOCIATES OF FLORIDA INC (NPI: 1528097284; TIN: 593549147) and primary practice location at 32163-2040. Whitney is affiliated with the Rancho Health Management, LLC (ACO ID: D0015), participating under the REACH model.

Whitney's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,069 traditional Medicare patients, billed 6,709 HCPCS/CPT codes, and received $388,861 in Medicare payments. The top billing code was 17110 (Destruction of skin growth, 1-14 growths). Part D data shows 1,916 prescription claims across 871 beneficiaries totaling $802,841 in drug costs, led by Humira(Cf) Pen (Adalimumab). Open Payments data shows 36 records totaling $888. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $241 to $802,841. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$194K$389K2023 Medicare payment: $123,807 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $388,861 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
2022N/RN/RN/R
20234372,208$123,807
20241,0696,709$388,861

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$401K$803K2019 Drug cost: $241 (USD; Tot_Drug_Cst)2020 Drug cost: $1,296 (USD; Tot_Drug_Cst)2021 Drug cost: $13,578 (USD; Tot_Drug_Cst)2022 Drug cost: $70,504 (USD; Tot_Drug_Cst)2023 Drug cost: $19,063 (USD; Tot_Drug_Cst)2024 Drug cost: $802,841 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
20191420$241
2020N/R16$1,296
20211322$13,578
20222866$70,504
2023243398$19,063
20248711,916$802,841

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
17110Destruction of skin growth, 1-14 growths273326$75
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more634841$60
11102Biopsy of related skin growth, first growth277325$59
17000Destruction of precancer skin growth, 1 growth565727$34
17003Destruction of precancer skin growth, 2-14 growths4062,347$5

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Humira(Cf) PenAdalimumab11364$179,912
Dupixent PenDupilumab26826$113,386
Clobetasol PropionateClobetasol Propionate35410,053$14,582
Doxycycline Ir-DrDoxycycline Monohydrate11330$6,018
KetoconazoleKetoconazole2928,294$5,847

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.36$888E.R. Squibb & Sons, L.L.C.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Zackary Bryce Whitney, DO?

Tedicare shows public-source Medicare data for Zackary Bryce Whitney, DO (NPI 1942763941), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Zackary Bryce Whitney, DO have ACO affiliation data?

Zackary Bryce Whitney, DO is shown with ACO affiliation data for Rancho Health Management, LLC (REACH, ACO ID D0015).

What billing organization is linked to Zackary Bryce Whitney, DO?

Zackary Bryce Whitney, DO is linked to LEAVITT MEDICAL ASSOCIATES OF FLORIDA INC (billing NPI 1528097284) in the available physician profile data.

Does Zackary Bryce Whitney, DO have Open Payments data?

Zackary Bryce Whitney, DO has 36 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.